Navigation Links
The German National Academy of Sciences Leopoldina sets up new standing committees
Date:3/25/2011

The German National Academy of Sciences Leopoldina has set up seven new standing committees in order to be able to work more intensively on topics of the future. The task of these groups is to follow scientific discussion in their respective fields, investigate and discuss important future topics and to initiate activities in the area of policy advice. The results of this could be short-term statements on acute issues or middle or long term statements on future topics for which larger, interdisciplinary workgroups are employed. The new committees deal with "Health", "Ageing and Fertility", "Structure of the research system", "Acceptance of new technologies", "Life Sciences", "Climate, Energy and the Environment" and "Science and Ethics".

The President of the Leopoldina, Jrg Hacker, is pleased with the developments of the German National Academy of Sciences after his first year in office. "The Leopoldina contributes actively and independently to political decision-making processes. Recommendations, such as the Statement on preimplantation genetic diagnosis issued at the beginning of the year, demonstrate how socially-relevant topics are able to be taken up, studied in an interdisciplinary manner and introduced into public discussion," explains Hacker. The Leopoldina has established the seven new standing committees in which high-ranking scientists study socially-relevant topics for the future in order to strengthen the Academy's position in giving advice to society and policy makers

Last year the Leopoldina issued three statements. The drafting of these statements was led by the Leopoldina and done in collaboration with other academies. The statement published in January 2011 on preimplantation genetic diagnosis recommended allowing this diagnosis procedure in Germany under tight restrictions. This would allow families at high risk of having a child with a severe hereditary disease to have a child that is not affected by this disease. The statement issued in October 2010 on "predictive genetic diagnostics" expressed recommendations for dealing with a still-young, seminal branch of medicine: genetic testing on healthy people to prevent diseases. In light of the amendment to the EU directive on animal testing, the Leopoldina furthermore provided a differentiated balancing of interests between animal protection and the needs of health research. Recently, a new workgroup entitled "Personalised Medicine" was established to study the challenges faced by the forms of diagnosis and therapy that will be more tailored to the patient in the future.

"The voice of science and the clustered expertise of the excellent researchers gathered at the Leopoldina are more and more in demand. Our recommendations on many other topics are being eagerly awaited. Thus, it is not difficult to continue along the path set out by my predecessor Prof. Volker ter Meulen," says Leopoldina President Jrg Hacker.


'/>"/>

Contact: Caroline Wichmann
presse@leopoldina.org
49-345-472-39800
Leopoldina
Source:Eurekalert

Related medicine news :

1. National license for Springer eBooks signed in Germany
2. Public health systems compared: Germans more dissatisfied than the rest
3. Frontiers in Cardiovascular Biology: July 16-19, 2010, Berlin, Germany
4. Bowel cancer: 8 years of colonoscopy screening in Germany -- a success story
5. NationalCreditReport.com Reminds Consumers of Ways to Improve Credit Report and Score in 2010
6. The National Coalition for Cancer Survivorship Joins the Commission on Cancer
7. National Wildlife Federation Says Outdoor Time for Kids Can Help First Lady Achieve Her “Let's Move” Goal
8. Howard Dean to Speak at the 2010 DTC National Conference
9. International Diabetes Federation awards $2 million to 9 global diabetes research projects
10. Jion Beijing Great Wall International Travel Agency Immediate Exposure to China Expo 2010
11. U.S. National Guard Connects Nationwide with Desktop Alert's Command and Control Mass Notification Systems and Common Alerting Protocol (CAP)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... ... May 03, 2016 , ... California health startup Pegara announced ... helps people assess their risk of developing Alzheimer’s disease. Using a questionnaire based ... “Risk Reduction Score™” that summarizes how their lifestyle choices may affect their chances ...
(Date:5/3/2016)... Yorba Linda, CA (PRWEB) , ... May 03, ... ... exponential enrichment) is a process that selects DNA or RNA from a random ... ligands—called aptamers—could potentially be used as drugs or diagnostic agents. SELEX selection is ...
(Date:5/3/2016)... ... May 03, 2016 , ... Elizabeth Murray has always loved walking ... her with one on her shoulder and one on her arm. But she got ... of years of mitral valve prolapse. , The valves of the heart wouldn’t close ...
(Date:5/3/2016)... ... May 03, 2016 , ... Diagnotes, a leader in ... a three hospital system in South Carolina, to provide its secure mobile communication ... that enhances communication, drives workflow efficiencies and improves provider and patient satisfaction,” said ...
(Date:5/3/2016)... , ... May 03, 2016 , ... Each year, about ... cause of death across the United States and account for one death every four ... impairments or are permanently disabled. HCR ManorCare is launching a video series called “Your ...
Breaking Medicine News(10 mins):
(Date:5/3/2016)... , May 3, 2016 ... Report provides a basic overview of the industry ... which the surgical mesh report explores into the ... Complete report on Surgical Mesh market spread ... 98 tables and figures is available at ...
(Date:5/2/2016)... Leading Economies with Fastest Real GDP Annual Percentage Change, 2015  ... 7.3, , Source: IMF and TechSci Research   ... Brazil , Russia , India , ... the fastest GDP growth during the first decade of the 21 st ... Brazil and Russia , along with policy ...
(Date:5/2/2016)... , May 2, 2016  Celsion Corporation (NASDAQ: ... company, today announced data from the first cohort ... clinical trial (the OVATION Study) combining GEN-1, the ... for the treatment of newly-diagnosed patients with advanced ... by interval debulking surgery.  In the first three ...
Breaking Medicine Technology: